Computational Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland.
Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
J Intern Med. 2022 Jul;292(1):146-153. doi: 10.1111/joim.13479. Epub 2022 Mar 22.
Observational findings for high-density lipoprotein (HDL)-mediated cholesterol efflux capacity (HDL-CEC) and coronary heart disease (CHD) appear inconsistent, and knowledge of the genetic architecture of HDL-CEC is limited.
A large-scale observational study on the associations of HDL-CEC and other HDL-related measures with CHD and the largest genome-wide association study (GWAS) of HDL-CEC.
PARTICIPANTS/METHODS: Six independent cohorts were included with follow-up data for 14,438 participants to investigate the associations of HDL-related measures with incident CHD (1,570 events). The GWAS of HDL-CEC was carried out in 20,372 participants.
HDL-CEC did not associate with CHD when adjusted for traditional risk factors and HDL cholesterol (HDL-C). In contradiction, almost all HDL-related concentration measures associated consistently with CHD after corresponding adjustments. There were no genetic loci associated with HDL-CEC independent of HDL-C and triglycerides.
HDL-CEC is not unequivocally associated with CHD in contrast to HDL-C, apolipoprotein A-I, and most of the HDL subclass particle concentrations.
关于高密度脂蛋白(HDL)介导的胆固醇流出能力(HDL-CEC)与冠心病(CHD)的观察结果似乎不一致,且对 HDL-CEC 的遗传结构知之甚少。
本研究开展了一项针对 HDL-CEC 与其他 HDL 相关指标与 CHD 之间关联的大规模观察性研究,以及针对 HDL-CEC 的最大全基因组关联研究(GWAS)。
参与者/方法:纳入了 6 个独立队列,随访了 14438 名参与者,以调查 HDL 相关指标与冠心病(1570 例事件)的发病风险之间的关联。在 20372 名参与者中进行了 HDL-CEC 的 GWAS。
在调整传统危险因素和高密度脂蛋白胆固醇(HDL-C)后,HDL-CEC 与 CHD 无关。相反,在进行相应调整后,几乎所有与 HDL 相关的浓度指标都与 CHD 一致相关。没有与 HDL-C 和甘油三酯无关的独立于 HDL-CEC 的遗传位点。
与 HDL-C、载脂蛋白 A-I 和大多数 HDL 亚类颗粒浓度不同,HDL-CEC 与 CHD 没有明确关联。